Want to see ACHV full AI Analyst Report?
Achieve Life Sciences (ACHV) Ratios
Achieve Life Sciences Ratios
ACHV's free cash flow for Q2 2026 was $-10.79M. For the 2026 fiscal year, ACHV's free cash flow was decreased by $-16.00K and operating cash flow was $-10.78M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 4.39 | 5.46 | 0.82 | 1.27 | 9.80 |
| Quick Ratio | 4.39 | 5.46 | 0.82 | 1.27 | 9.80 |
| Cash Ratio | 2.30 | 1.91 | 0.75 | 1.14 | 9.46 |
| Solvency Ratio | -2.68 | -2.23 | -1.42 | -1.94 | -1.69 |
| Operating Cash Flow Ratio | -5.45 | -4.46 | -1.18 | -1.74 | -6.47 |
| Short-Term Operating Cash Flow Coverage | -13.35 | 0.00 | -1.47 | -2.34 | 0.00 |
| Net Current Asset Value | $ 19.62M | $ 18.73M | $ -3.84M | $ 5.66M | $ 25.12M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.36 | 0.26 | 0.86 | 0.54 | 0.32 |
| Debt-to-Equity Ratio | 0.69 | 0.48 | -11.55 | 1.95 | 0.53 |
| Debt-to-Capital Ratio | 0.41 | 0.32 | 1.09 | 0.66 | 0.35 |
| Long-Term Debt-to-Capital Ratio | 0.34 | 0.32 | 0.00 | 0.00 | 0.35 |
| Financial Leverage Ratio | 1.94 | 1.85 | -13.38 | 3.61 | 1.69 |
| Debt Service Coverage Ratio | -11.85 | -17.16 | -1.37 | -2.26 | 0.00 |
| Interest Coverage Ratio | -67.01 | -17.92 | -9.55 | -22.81 | 0.00 |
| Debt to Market Cap | 0.07 | 0.09 | 0.20 | 0.62 | 0.24 |
| Interest Debt Per Share | 0.36 | 0.38 | 0.99 | 1.70 | 1.85 |
| Net Debt to EBITDA | 0.11 | 0.07 | -0.04 | 0.21 | 0.85 |
| Profitability Margins | |||||
| Gross Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| EBIT Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| EBITDA Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Operating Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Pretax Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Net Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Continuous Operations Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Net Income Per EBT | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% |
| EBT Per EBIT | 99.58% | 101.94% | 109.41% | 103.80% | 100.18% |
| Return on Assets (ROA) | -130.77% | -103.09% | -153.92% | -141.30% | -69.77% |
| Return on Equity (ROE) | -253.96% | -190.57% | 2059.05% | -510.06% | -118.22% |
| Return on Capital Employed (ROCE) | -167.79% | -122.28% | 1889.74% | -487.34% | -77.02% |
| Return on Invested Capital (ROIC) | -150.47% | -122.07% | -178.30% | -166.52% | -76.90% |
| Return on Tangible Assets | -136.60% | -108.74% | -173.95% | -153.89% | -73.93% |
| Earnings Yield | -25.22% | -35.28% | -36.50% | -163.18% | -52.48% |
| Efficiency Ratios | |||||
| Receivables Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Payables Turnover | 0.26 | 0.12 | 0.00 | 0.00 | 0.00 |
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Fixed Asset Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Asset Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Working Capital Turnover Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | -1387.96 | -3108.08 | 0.00 | 0.00 | 0.00 |
| Days of Sales Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Inventory Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Payables Outstanding | 1387.96 | 3108.08 | 0.00 | 0.00 | 0.00 |
| Operating Cycle | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -1.13 | -0.93 | -1.23 | -3.55 | -3.63 |
| Free Cash Flow Per Share | -1.13 | -0.93 | -1.24 | -3.55 | -3.63 |
| Dividend Paid and CapEx Coverage Ratio | -16488.33 | 0.00 | -1165.67 | 0.00 | 0.00 |
| Capital Expenditure Coverage Ratio | -16488.33 | 0.00 | -1165.67 | 0.00 | 0.00 |
| Operating Cash Flow Coverage Ratio | -3.31 | -2.99 | -1.46 | -2.32 | -1.96 |
| Operating Cash Flow to Sales Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Free Cash Flow Yield | -22.83% | -26.37% | -29.99% | -144.76% | -46.60% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -3.98 | -2.84 | -2.74 | -0.61 | -1.91 |
| Price-to-Sales (P/S) Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Price-to-Book (P/B) Ratio | 10.07 | 5.40 | -56.41 | 3.13 | 2.25 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -4.38 | -3.79 | -3.33 | -0.69 | -2.15 |
| Price-to-Operating Cash Flow Ratio | -4.38 | -3.79 | -3.34 | -0.69 | -2.15 |
| Price-to-Earnings Growth (PEG) Ratio | -4.93 | 0.16 | 0.04 | 0.25 | 0.08 |
| Enterprise Value Multiple | -3.93 | -2.94 | -3.10 | -0.43 | -1.07 |
| Enterprise Value | 210.69M | 110.12M | 82.87M | 17.43M | 35.14M |
| EV to EBITDA | -3.93 | -2.94 | -3.10 | -0.43 | -1.07 |
| EV to Sales | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EV to Free Cash Flow | -4.26 | -3.70 | -3.38 | -0.46 | -1.19 |
| EV to Operating Cash Flow | -4.26 | -3.70 | -3.39 | -0.46 | -1.19 |
| Tangible Book Value Per Share | 0.45 | 0.59 | -0.19 | 0.55 | 3.12 |
| Shareholders’ Equity Per Share | 0.49 | 0.65 | -0.07 | 0.78 | 3.45 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Revenue Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income Per Share | -1.25 | -1.24 | -1.50 | -4.00 | -4.08 |
| Tax Burden | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Interest Burden | 1.02 | 1.06 | 1.11 | 1.04 | 1.00 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 0.91 | 0.75 | 0.82 | 0.89 | 0.89 |
Currency in USD
